Drug Delivery System

Drug Delivery System encompasses technologies, formulations, and devices designed to control the release, absorption, distribution, and elimination of pharmaceutical agents, optimising therapeutic efficacy while minimising adverse effects through precise temporal and spatial control of drug exposure. These sophisticated platforms range from simple oral tablets with modified release profiles to complex implantable devices, transdermal patches, inhalation systems, and targeted nanoparticle formulations that address challenges including poor bioavailability, rapid metabolism, systemic toxicity, or inability to reach therapeutic targets.

The pharmaceutical industry develops diverse delivery systems addressing specific therapeutic needs across all administration routes. Oral delivery systems employ polymer matrices, coatings, or multiparticulate designs achieving sustained release from single doses, improving compliance while reducing side effects. Injectable depot formulations using biodegradable microspheres or implants provide weeks to months of drug delivery from single administrations, particularly valuable for chronic conditions. Transdermal systems deliver drugs through skin, offering non-invasive administration and avoiding first-pass metabolism. Pulmonary delivery systems optimise particle sizes and formulations for deep lung deposition. Targeted delivery systems incorporate ligands, antibodies, or stimuli-responsive elements directing accumulation at disease sites. As biologics proliferate requiring parenteral administration and patient-centric healthcare emphasises convenience, drug delivery innovation continues through smart materials, biodegradable polymers, microfluidic devices, and personalised systems.